Indaptus Therapeutics News

Indaptus Therapeutics | 424B5: Prospectus

Mar 13 17:05 ET

Indaptus Therapeutics | 424B5: Prospectus

Mar 27, 2023 17:10 ET

Indaptus Therapeutics | EFFECT: Others

Jan 3, 2023 00:15 ET

Indaptus Therapeutics | 424B3: Prospectus

Dec 30, 2022 16:36 ET

Indaptus Therapeutics | EFFECT: Others

Sep 12, 2022 00:15 ET

Indaptus Therapeutics | EFFECT: Others

Mar 24, 2022 00:15 ET

Indaptus Therapeutics | EFFECT: Others

Dec 2, 2021 00:15 ET

Indaptus Therapeutics | EFFECT: Others

Sep 30, 2021 00:15 ET

Indaptus Therapeutics | 424B3: Prospectus

Sep 29, 2021 13:20 ET

Indaptus Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 29, 2021 17:17 ET

Indaptus Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 23, 2021 16:33 ET

Indaptus Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Jul 23, 2021 16:11 ET

Indaptus Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 16, 2021 17:12 ET